Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on July 26, 2016. The report announces the consolidated financial results for the fourth quarter and the full fiscal year ended May 29, 2016.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that results have been issued and directs readers to the attached press release for details.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. The document explicitly states that the information in the press release (Exhibit 99.1) is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (the press release) for actual financial figures, as they are absent from the 8-K body text.
- Confirm the fiscal year end date of May 29, 2016 when comparing to other periods.
- Note that the financial data in the press release is not legally "filed" under Section 18 of the Exchange Act per this report's disclaimer.